关键护理药物治疗文献中的主要出版物:2024年
Alyson M Esteves1, Brittney Bernardoni2, Sophia Brown3
1Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA.
Journal of critical care
|July 17, 2025
概括
本综述强调了2024年关键的重症监护药物治疗研究. 它确定了对重症患者药物使用的有影响力的研究,指导临床实践.
科学领域:
- 临界护理医学 临界护理医学
- 药物治疗 药物治疗
- 临床研究 临床研究
背景情况:
- 重症护理药物治疗领域正在迅速发展.
- 识别具有高影响力的出版物对于基于证据的实践至关重要.
- 临床医生需要对最近的进展进行简要的总结.
研究的目的:
- 从2024年开始,系统地识别和分析最具影响力的重症监护药疗出版物.
- 提供这些关键研究的临床见解和摘要.
- 综合与关键病患者护理相关的新发现.
主要方法:
- 在PubMed/MEDLINE进行了全面的系统搜索,搜索了2024年的出版物.
- 纳入标准侧重于高质量的RCT,成年重症患者的前性或回顾性研究.
- 为了确定影响,使用了涉及多学科专家的三轮修改后的Delphi过程.
主要成果:
- 在1533篇文章中,41篇被纳入了德尔菲进程,最终有6篇被选中.
- 涵盖的关键主题包括PPI停止,压力的预防,治疗败血症的连续β-乳糖类药物,预防VAP的 ceftriaxone,抗生素持续时间和使用 andexanet alfa.
- 选择的研究代表了对科学知识和临床实践的重大贡献.
结论:
- 本综述成功地确定并总结了在2024年发表的重症监护药疗中的高影响性研究.
- 这些发现为管理重症患者提供了宝贵的临床见解.
- 这些选定的出版物预计将影响未来的重症监护药物治疗策略.
相关概念视频
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...